tlc-388
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- DNA topoisomerase IINHIBITOR
DNA topoisomerase I inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC[C@@]4(OC(=O)C(C)ON=C1C2=CC(=CC(=C2C3=C(C=C(C=C13)[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=O)OCC5=C4C=C6N(CC7=C6N=C8C=CC(O)=C(CN(C)C)C8=C7)C5=O- Mol. weight
- 850.7001 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSD47234N30N ↗
- ChEMBLCHEMBL4594352 ↗